10th Annual MSK Symposium on Lymphoma — On Demand


10th Annual MSK Symposium on Lymphoma — On Demand Banner



Date & Location
Thursday, June 11, 2026, 8:00 AM - Thursday, December 31, 2026, 2:00 PM

Specialties
Specialties - Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology

Overview

The 10th anniversary edition of the MSK Symposium on Lymphoma marks a decade of advances in lymphoma diagnosis, management, and therapy. This on demand program explores the rapidly evolving landscape of lymphoma research and clinical practice, highlighting advances in disease biology, diagnostic approaches, and therapeutic strategies that are transforming patient outcomes.

Bringing together distinguished experts from Memorial Sloan Kettering Cancer Center and leading institutions around the world, the program provides a comprehensive review of the clinical management of both common and emerging lymphoma subtypes. Through expert-led presentations, keynote lectures, panel discussions, and practical clinical guidance, faculty share the latest evidence and insights to support informed, individualized decision-making in an era of rapid scientific and therapeutic innovation.

Topics include advances in lymphoma biology and translational research, evolving treatment paradigms, contemporary diagnostic and pathology considerations, and multidisciplinary approaches to patient care. The program also features case-based panel discussions that address real-world clinical challenges and a dedicated session for allied health professionals, highlighting the essential and expanding role of the interprofessional care team in lymphoma management. 

By integrating the latest scientific discoveries with practical clinical insights, this program offers a comprehensive perspective on the advances shaping the future of lymphoma care.

This activity is designed for hematologists, medical oncologists, radiation oncologists, hematopathologists, internists, scientists, advanced practice providers, nurses, pharmacists, and trainees involved in the diagnosis, treatment, and research of lymphoma.

Please refer to the brochure from the live event for a full listing of topics covered in this activity.


Objectives
At the conclusion of this symposium, attendees will be able to:

  1. Describe recent advances in lymphoma diagnosis, helping navigate with recent advances in the WHO and ICC classifications
  2. Discuss first line treatment options in most frequent lymphoma entities
  3. Describe new agents mode of actions, efficacy, side effects
  4. Discuss options and recommendations for patients in the relapse refractory setting
  5. Provide strategies to help shared decision-making with patients regarding their treatment

Registration

Access to the symposium content requires registration. Once registered, all materials, including instructions for claiming credit, are located under the Course Content tab. For those that purchase this on demand, access to the content and the opportunity to claim credit will be available through December 30, 2026. To enroll, please click the Register tab at the top of the page.

On Demand Fees

  • Physicians (MDs, PhDs, DOs): $450

  • Advanced Practice Providers: $200

  • Nurses and Other Healthcare Professionals: $150

  • Residents, Fellows, and Trainees: $100

  • MSK Employees: Complimentary

Discounted registration is available for specific groups, including complimentary registration for health professional students and registrants who reside in low and lower-middle income countries. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable. For details please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 14.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and

  • 14.50 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.


Content for this Activity was Recorded/Reviewed: April 10-11, 2026
Original Release Date: June 11, 2026
Termination Date: December 31, 2026